Table 4 Perceived negative effects associated with the use of prescription stimulants, survey in French-speaking universities, Belgium, 2018
Negative effects | Medical users (N=180) | Misusers (N=245) | p-valueb | ||
|---|---|---|---|---|---|
n (%) | 95%CI† | n (%) | 95%CI a | ||
Sleep disorders | 103 (57.2) | 49.6-64.6 | 142 (58.0) | 51.5-64.2 | 0.9 |
Palpitations | 70 (38.9) | 31.7-46.4 | 131 (53.8) | 47.0-59.8 | 0.003 |
Emotional instability | 84 (46.7) | 39.2-54.2 | 105 (42.9) | 36.6-49.3 | 0.4 |
Agitation | 47 (26.1) | 19.9-33.2 | 93 (38.0) | 31.9-44.4 | 0.01 |
Aggressiveness | 54 (30.0) | 23.4-37.3 | 71 (29.0) | 23.4-35.1 | 0.8 |
Headaches | 33 (18.3) | 13.0-24.8 | 73 (29.8) | 24.1-35.9 | 0.007 |
Depression | 62 (34.4) | 27.5-41.9 | 57 (23.3) | 18.1-29.1 | 0.01 |
Nausea | 47 (26.1) | 19.9-33.2 | 40 (16.3) | 11.9-21.6 | 0.01 |
Anorexia | 51 (28.3) | 21.8-35.5 | 39 (15.9) | 11.6-21.1 | 0.002 |
Suicidal thoughts | 26 (14.4) | 9.7-20.4 | 27 (11.0) | 7.4-15.6 | 0.3 |
Hallucinations | 9 (5.0) | 2.3-9.3 | 12 (4.9) | 2.6-8.4 | >0.9 |
Other | 33 (18.3) | 13.0-24.8 | 28 (11.4) | 7.7-16.1 | 0.04 |